Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified Glasgow prognostic score
2020; Springer Science+Business Media; Volume: 277; Issue: 8 Linguagem: Inglês
10.1007/s00405-020-05945-5
ISSN1434-4726
AutoresYushi Ueki, Takeshi Takahashi, Hisayuki Ota, Ryusuke Shodo, Keisuke Yamazaki, Arata Horii,
Tópico(s)Head and Neck Cancer Studies
Referência(s)